In an interview with EcoWatch last month, Robert F. Kennedy Jr. reiterated his previous statements that the “CDC is a subsidiary of the pharmaceutical industry. The agency owns more than 20 vaccine patents and purchases and sells $4.1 billion in vaccines annually.”
In efforts to fact-check RFK Jr.’s claims, board members with HealthChoice.org and the Director of the Maine Coalition for Vaccine Choice have conducted an independent investigation to uncover just how many vaccine patents are in fact registered to the CDC.
I have been around long enough to know that vaccine claims have to be checked and rechecked. And since this is a very old claim, one that I would like to be able to state (if it is true), I decided to review it.
I am fortunate to have, as one of my partners in advocacy, fellow autism parent Mark Blaxill, an Intellectual Property expert who has been employed by billion dollar corporations to manage their patents.
Blaxill was the man who found out that HHS, through NIH, owns patents on all HPV vaccines, and receives a percentage of the profits for each dose of Gardasil and Cervarix administered anywhere in the world. He published the stunning revelation in a detailed three part expose entitled, “A License to Kill? Part 1: How A Public-Private Partnership Made the Government Merck’s Gardasil Partner.” When I contacted Blaxill to ask how to run a patent search, he was kind enough to do it for me.
He found 57 granted US patents with the CDC listed as an assignee. You can see the search results here.
Upon cursory review of the patents, I found that one did not seem applicable to vaccination, but merely referenced an article on vaccination. That leaves us with 56 CDC patents to scrutinize.
Here is what I found.
There are CDC patents applicable to vaccines for Flu, Rotavirus, Hepatitis A, HIV, Anthrax, Rabies, Dengue fever, West Nile virus, Group A Strep, Pneumococcal disease, Meningococcal disease, RSV, Gastroenteritis, Japanese encephalitis, SARS, Rift Valley Fever, and chlamydophila pneumoniae.
There is a CDC patent for “Nucleic acid vaccines for prevention of flavivirus infection,” which has applications in vaccines for Zika, West Nile virus, Dengue fever, tick-borne encephalitis virus, yellow fever, Palm Creek virus, and Parramatta River virus. (Source)
CDC also has several patents for administering various ”shots” via aerosol delivery systems for vaccines. (Source)
There’s a CDC patent on a process for vaccine quality control by “quantifying proteins in a complex preparation of uni- or multivalent commercial or research vaccine preparations.” (Source)
There’s a CDC patent on a method “for producing a model for evaluating the antiretroviral effects of drugs and vaccines.” (Source)
CDC has a patent for companies who want to test their respiratory system applicable vaccine on an artificial lung system. (Source)
If a vaccine maker is concerned that their vaccine might contain a human rhinovirus, CDC has a patent on a process for determining if such contamination exists. (Source)
CDC has a patent on an assay to assist vaccine makers in finding antigen-specific antibodies in a biological sample. (Source)
CDC holds a patent that provides vaccine makers with a method of “reducing the replicative fitness of a pathogen by deoptimizing codons.” Asserting that, “pathogens with deoptimized codons can be used to increase the phenotypic stability of attenuated vaccines.” (Source)
The agency also holds a patent on adjuvants for a vaccine used on premature infants and young babies. (Source)
There is a CDC patent to cover a vaccine for an infection induced by a tape worm found in pork. (Source)
Does this seem like a public health agency making “independent” vaccine recommendations, or a private company with an impressive portfolio to which one might look for investment opportunities?